This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Stuart A. Chalew, MD; Laurence C. Udoff; Aaron Hanukoglu, MD; Tzvy Bistritzer, MD; Karen M. Armour, MD; A. Avinoam Kowarski, MD

Am J Dis Child. 1988;142(12):1345-1348.

Abstract
• Testosterone treatment is known to improve growth hormone (GH) secretion in boys with constitutional delay (CD). To determine whether spontaneous GH secretion is normal after treatment, we assessed GH secretion before and after a four- to five-month course of testosterone enanthate in eight adolescents with CD. Before testosterone therapy, the mean (±1 SD) 24-hour integrated concentration of GH (IC-GH) by constant blood withdrawal technique was 1.7±1.0 µg/L (normal range for age, 3.2 to 11.5 µg/L), and the IC-testosterone was 1.8±2.7 nmol/L. Two patients restudied during treatment had normal IC-GH values. After testosterone treatment, the mean IC-GH of the entire group was 3.3±2.6 µg/L, and the IC-testosterone was 6.5±5.3 nmol/L. Five of eight patients had IC-GH values that were again subnormal. A subnormal IC-GH associated with CD may persist after testosterone therapy is discontinued. Deficiency of spontaneous GH secretion may contribute to short stature and slower growth rates in this patient group. Whether GH therapy in these patients would have a beneficial effect on final height is unknown.

(AJDC 1988;142:1345-1348)

Author Affiliations
From the Department of Pediatrics, University of Maryland School of Medicine, Baltimore.

Footnotes
Accepted for publication Aug 15, 1988.

Reprint requests to University of Maryland School of Medicine, Division of Pediatric Endocrinology, BRB 10-047, 655 W Baltimore St, Baltimore, MD 21201 (Dr Chalew).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Factors Other than Sex Steroids Modulate GHRH and GHRP-2 Efficacies in Men: Evaluation Using a GnRH Agonist/Testosterone Clamp
Veldhuis and Bowers
J. Clin. Endocrinol. Metab. 2009;94:2544-2550.
ABSTRACT | FULL TEXT  

Determinants of GH-releasing hormone and GH-releasing peptide synergy in men
Veldhuis and Bowers
Am. J. Physiol. Endocrinol. Metab. 2009;296:E1085-E1092.
ABSTRACT | FULL TEXT